© 2019 by João Conde


Fundaçao para a Ciência e Tecnologia
European Research Council ERC

Principal Investigator

João Conde, PhD

  • LinkedIn Joao Conde
  • Twitter Conde NanoLab
  • publons
  • orcid

    João Conde received his PhD in Biology, specialty in NanoBiotechnology from the NOVA University and Universidad de Zaragoza in 2014, under the FP7 European Consortium NanoScieE+ – NANOTRUCK for the development of multifunctional gold nanoparticles for gene silencing. After, he was a Marie Curie Fellow at the Massachusetts Institute of Technology, Harvard-MIT Division for Health Sciences and Technology and in School of Engineering and Materials Science, Queen Mary University of London. He joined IMM in 2017 as a Junior Investigator. In 2019, he won an ERC Starting Grant to build a genetic biobarcode to profile breast cancer heterogeneity.

     His scientific interests are focused in the application of multifunctional nano-and-biomaterials for cancer therapy and diagnosis, especially for tumour imaging and targeting, gene therapy and drug delivery.

    The main aspects related to the recognition and diffusion of his early contributions are: 60 articles in journals in fields of Cancer therapy, Materials Science and Biomedicine, more than 30 articles are as 1st author and more than 20 articles as corresponding author and cited more than 3300 times (h-index 32). Four of them have been selected as cover page of journals such as Adv. Functional Materials, Adv. Healthcare Materials, Analytical and Bioanalytical Chemistry and BioTechniques. Moreover, 6 international patents were submitted and approved, all with relevant developments in nanomaterials-based platforms for cancer therapy and diagnosis. He was also awarded with several international awards, including the Wellcome Image Awards 2017, the Nano-Micro Letters Researcher Award, and the National Cancer Institute Image award.